EVEON has developed an airless spray nozzle that can be used to produce fine droplets in the form of a mist. This spray nozzle can be integrated into dedicated automatic medical devices to facilitate the administration of treatments by the patient, or simply connected directly to a syringe.

EVEON has signed a collaboration agreement with BEPATIENT to produce patient-centric digital solutions that serve both clinical research and digital therapeutics applications.

EVEON is proposing to automate and deliver multidose drugs from a vial, as well as vaccines used in the context of the Covid-19 pandemic.

EVEON carried out many innovative projects in 2020. This new year is also promising for the company driven forward by this positive dynamics.

EVEON celebrated its 10th anniversary and is ranked by Forbes as the 3rd most inventive French company in the medical technologies category.

The presentation of the DIPSA project, needle-free piezoelectric injection device, to the Auvergne Rhone Alpes region, as part of the call for R&D booster projects, received a favourable opinion in March 2019. The project was launched on Tuesday, April 15, 2019, at Cedrat Technologies (CTEC), project coordinator, with EVEON, as industrial partner, and the Grenoble Rheology and Processes Laboratory (LRP). 

EVEON, as part of a partnership with a pharmaceutical laboratory, has delivered, on schedule, the first functional prototypes based on the innovative medical device Intuity® Ject.

EVEON is announcing that it has forged a partnership with a pharmaceutical laboratory for a development based on the innovative Intuity® Ject medical device, recipient of a 2017 Pharmapack Award.

EVEON and six French companies have sealed a unique partnership called JBT HubUp a unique solution for developing innovative medical devices.